Form 8-K - Current report:
SEC Accession No. 0001140361-25-008918
Filing Date
2025-03-17
Accepted
2025-03-17 08:18:24
Documents
19
Period of Report
2025-03-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20045585x2_8k.htm   iXBRL 8-K 39383
2 EXHIBIT 4.1 ny20045585x2_ex4-1.htm EX-4.1 45957
3 EXHIBIT 5.1 ny20045585x2_ex5-1.htm EX-5.1 103054
4 EXHIBIT 5.2 ny20045585x2_ex5-2.htm EX-5.2 21689
9 ny20045585x2_ex5-1logo01.jpg GRAPHIC 2770
10 ny20045585x2_ex5-2img01.jpg GRAPHIC 87668
  Complete submission text file 0001140361-25-008918.txt   551363

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA imcr-20250317.xsd EX-101.SCH 4619
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imcr-20250317_def.xml EX-101.DEF 17473
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20250317_lab.xml EX-101.LAB 26289
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20250317_pre.xml EX-101.PRE 19658
21 EXTRACTED XBRL INSTANCE DOCUMENT ny20045585x2_8k_htm.xml XML 6417
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 25742461
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)